Daiwa Securities Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16
Closed 1280
2024
Q4
$0 Sell
16
-1
-6% -$9 ﹤0.01% 1284
2024
Q3
$0 Hold
17
﹤0.01% 1283
2024
Q2
$0 Sell
17
-795
-98% -$15.9K ﹤0.01% 1321
2024
Q1
$21K Sell
812
-52
-6% -$1.33K ﹤0.01% 1134
2023
Q4
$24K Sell
864
-290
-25% -$17.7K ﹤0.01% 1115
2023
Q3
$70K Hold
1,154
﹤0.01% 1042
2023
Q2
$76K Buy
1,154
+686
+147% +$50.2K ﹤0.01% 1046
2023
Q1
$30K Buy
468
+89
+23% +$10.2K ﹤0.01% 1062
2022
Q4
$52K Buy
379
+367
+3,058% +$51.7K ﹤0.01% 1033
2022
Q3
$1K Sell
12
-1,111
-99% -$126K ﹤0.01% 1276
2022
Q2
$93K Buy
1,123
+1,111
+9,258% +$86.2K ﹤0.01% 1032
2022
Q1
$1K Hold
12
﹤0.01% 1296
2021
Q4
$2K Sell
12
-6
-33% -$1.42K ﹤0.01% 1275
2021
Q3
$4K Buy
18
+8
+80% +$2.29K ﹤0.01% 1190
2021
Q2
$4K Hold
10
﹤0.01% 1083
2021
Q1
$4K Hold
10
﹤0.01% 1087
2020
Q4
$5K Sell
10
-18
-64% -$11.4K ﹤0.01% 1055
2020
Q3
$20K Buy
28
+4
+17% +$3.12K ﹤0.01% 990
2020
Q2
$14K Hold
24
﹤0.01% 1044
2020
Q1
$14K Hold
24
﹤0.01% 1031
2019
Q4
$27K Sell
24
-3
-11% -$3.26K ﹤0.01% 994
2019
Q3
$32K Hold
27
﹤0.01% 976
2019
Q2
$44K Sell
27
-299
-92% -$517K ﹤0.01% 970
2019
Q1
$665K Sell
326
-154
-32% -$271K 0.01% 568
2018
Q4
$617K Sell
480
-714
-60% -$1.1M 0.01% 546
2018
Q3
$2.26M Sell
1,194
-4
-0.3% -$8.26K 0.02% 349
2018
Q2
$2.44M Buy
1,198
+333
+38% +$759K 0.02% 344
2018
Q1
$1.91M Buy
865
+59
+7% +$150K 0.02% 380
2017
Q4
$1.86M Sell
806
-836
-51% -$1.7M 0.01% 394
2017
Q3
$2.92M Buy
1,642
+338
+26% +$472K 0.02% 282
2017
Q2
$1.77M Buy
+1,304
New +$1.57M 0.01% 345

Other funds holding BLUE

Daiwa Securities Group's BLUE Position: Q1 2025 in Review

Daiwa Securities Group sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 16 shares.

Daiwa Securities Group first reported a position in BLUE in Q2 2017 and held it in 31 quarters. The position peaked at $2.92M in Q3 2017. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Daiwa Securities Group reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 16 bluebird bio shares in Q1 2025.
  • Daiwa Securities Group first reported a position in bluebird bio in Q2 2017 and held it in 31 quarters.
  • Daiwa Securities Group's bluebird bio position peaked at $2.92M in Q3 2017.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.